It’s time for a change
March 1, 2022
Much has been written about the challenges frontline health care workers have faced during the COVID-19 pandemic. Long hours, excessive death, and fear for one’s own safety and the welfare of...
Outpatient COVID-19 therapeutics reduce hospitalization and mortality
February 10, 2022
Matching the right patient to the right therapeutic at the right time In late 2021 and early 2022, the Food and Drug Administration (FDA) granted emergency use authorizations (EUAs) for the...
Hospitalists demonstrate resiliency in the face of challenge
February 3, 2022
Dr. Verplanke As he reflected upon his days as a hospitalist and unit medical director within the division of hospital medicine at NYU Langone Health in New York, since the COVID-19 pandemic...
Addressing the nursing shortage
January 7, 2022
Dr. Hannapel With the onset of COVID-19, the existing nurse shortage only worsened at many hospitals throughout the country. “COVID patients require an extra level of care due to the virus’s...
Empiric therapeutic anticoagulation for severe COVID-19
January 7, 2022
Dr. Anderson Clinical question: For patients hospitalized with COVID-19, does empiric therapeutic-dose versus prophylactic-dose anticoagulation with enoxaparin affect clinical...
Epilepsy linked to 1.5-fold higher COVID-19 mortality in hospital
December 14, 2021
Findings suggest higher risk although researchers haven’t adjusted findings for confounders yet.
CDC unveils mental health protection plan for health care workers
November 22, 2021
“It’s long past time for us to care for the people who care for all of us and address burnout in our health care workers,” said U.S. Surgeon General Vivek Murthy.
Substance abuse boosts COVID hospitalization, death risk, even after vaccination
October 15, 2021
Investigators found about twice as many individuals with an SUD had a breakthrough COVID-19 infection as their counterparts without an SUD.
Age, C-reactive protein predict COVID-19 death in diabetes
September 29, 2021
“This means we can easily identify patients early on in their hospital stay who will likely require more aggressive interventions to try and improve survival.”
Remdesivir sharply cuts COVID hospitalization risk, Gilead says
September 23, 2021
An RCT evaluated the efficacy and safety of a 3-day course of intravenous remdesivir in an analysis of 562 nonhospitalized patients at high risk for disease progression.